1. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007 Jun;28(12):1462-1536. doi: 10.1093/eurheartj/ehm236. PMID: 17562668
  2. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008 Jul;78(1):93-100. PMID: 18649616
  3. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009 Oct;122(10):890-895. doi: 10.1016/j.amjmed.2009.03.036. PMID: 19786154
  4. Management of the causes of infertility. In: Stenchever M. Comprehensive Gynecology. 4th ed. St. Louis: Mosby; 2001.
  5. Larsen PR, Kronenberg HM, et al. Disorders of the female reproductive system. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 10th ed. Philadelphia: Saunders, an imprint of Elsevier; 2003.
  6. Sibai BM. Hypertension. In: Gabbe SG, Nielby JR, Simpson JL. Gabbe: Obstetrics Normal and Problem Pregnancies. 5th ed. Philadelphia: Churchill Livingstone, Inc; 2007:901-903.
  7. Pituitary hormones and their hypothalamic releasing factors. In: Parker K, Schimmer B, Hardman J, et al. Goodman and Gilman's The Pharmacologic Basis of Therapeutics. 10th ed. New York: McGraw Hill Medical Publishing Division; 2007.
  8. MedWormhttp://www.medworm.com/rss/index.php/OBGYN/29/http://www.medworm.com/rss/medicalfeeds/specialities/OBGYN.xml
  9. MedWorm - Hypertensionhttp://www.medworm.com/rss/medicalfeeds/conditions/Hypertension-News.xml
  10. Magee LA, Pels A, Helewa M, et al; Hypertension Guideline Committee, Society of Obstetricians and Gynaecologists of Canada. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):416-438. http://sogc.org. PMID: 24927294
  11. American College of Obstetricians and Gynecologists. Committee opinion no. 623: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2015 Feb;125(2):521-525. doi: 10.1097/01.AOG.0000460762.59152.d7. Accessed 27 Jan 2015. PMID: 25611642
  12. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008 Apr;51(4):960-969. doi: 10.1161/HYPERTENSIONAHA.106.075895. Accessed 27 Jan 2015. PMID: 18259046
  13. Townsend R, O'Brien P, Khalil A. Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control. 2016 Jul 27;9:79-94. doi: 10.2147/IBPC.S77344. Accessed 26 May 2017. PMID: 27555797
  14. Malaysian Society of Hypertension, Ministry of Health Malaysia, Academy of Medicine of Malaysia. Clinical practice guidelines. Management of hypertension. 5th edition (2018). Academy of Medicine of Malaysia. http://www.acadmed.org.my. 2018. Accessed 07 Dec 2018.
  15. Tay JC, Sule AA, Chew EK, et al. Ministry of Health clinical practice guidelines: hypertension. Singapore Med J. 2018 Jan;59(1):17-27. doi: 10.11622/smedj.2018007. Accessed 17 Dec 2018. PMID: 29376186
  16. Committee on Obstetric Practice. ACOG Committee opinion no. 767: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2019 Feb;133(2):e174-e180. doi: 10.1097/AOG.0000000000003075. Accessed 11 Jul 2019. PMID: 30575639
  17. National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. NICE. https://www.nice.org.uk. 25 Jun 2019. Accessed 01 Jun 2020.
  18. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Accessed 01 Jun 2020. PMID: 32370572
  19. Committee on Practice Bulletins - Obstetrics. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020 Jun;135(6):e237-e260. doi: 10.1097/AOG.0000000000003891. Accessed 10 May 2021. PMID: 32443079
  20. World Health Organization (WHO). WHO recommendations on drug treatment for non-severe hypertension in pregnancy. WHO. https://www.who.int. 2020. Accessed 07 May 2021.
  21. Ona DID, Jimeno CA, Jasul GV, et al. Executive summary of the 2020 clinical practice guidelines for the management of hypertension in the Philippines. J Clin Hypertens (Greenwich). 2021 Aug 3:1-14. doi: 10.1111/jch.14335. Accessed 05 Aug 2021. PMID: 34343391
  22. American College of Obstetricians and Gynecologists’ Committee on Clinical Practice Guidelines-Obstetrics. Clinical guidance for the integration of the findings of the Chronic Hypertension and Pregnancy (CHAP) study. American College of Obstetricians and Gynecologists (ACOG). https://www.acog.org. Apr 2022.
  23. Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022 Mar;27:148-169. doi: 10.1016/j.preghy.2021.09.008. PMID: 35066406
  24. Garovic VD, Dechend R, Easterling T, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension. 2022 Feb;79(2):e21-e41. doi: 10.1161/HYP.0000000000000208. PMID: 34905954
  25. Magee LA, Smith GN, Bloch C, et al. Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management. J Obstet Gynaecol Can. 2022 May;44(5):547-571.E1. https://doi.org/10.1016/j.jogc.2022.03.002. Accessed 04 Apr 2022
  26. Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019 May;145(Suppl 1):1-33. doi: 10.1002/ijgo.12802. PMID: 31111484
  27. McEvoy JW, McCarthy CP, Bruno RM, et al; ESC Scientific Document Group. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024 Aug 30:ehae178. doi: 10.1093/eurheartj/ehae178. Accessed 31 Aug 2024. PMID: 39210715
  28. Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Aug 14. doi: 10.1161/CIR.0000000000001356. Accessed 15 Apr 2026. PMID: 40811497
  29. De Backer J, Haugaa KH, Hasselberg NE, et al; ESC Scientific Document Group. 2025 ESC guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J. 2025 Aug 29:ehaf193. doi: 10.1093/eurheartj/ehaf193. PMID: 40878294
  30. Broekhuijsen K, van Baaren GJ, van Pampus MG, et al; HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2492-2501. doi: 10.1016/S0140-6736(14)61998-X. PMID: 25817374
  31. Hauspurg A, Jeyabalan A. Postpartum preeclampsia/eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2021 Jul 7;226(Suppl 2):S1211–S1221. doi: 10.1016/j.ajog.2020.10.027. PMID: 35177218
  32. Koopmans CM, Bijlenga D, Groen H, et al; HYPITAT study group. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009 Sep 19;374(9694):979-988. doi: 10.1016/S0140-6736(09)60736-4. PMID: 19656558
  33. Tita AT, Szychowski JM, Boggess K, et al; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022 May 12;386(19):1781-1792. doi: 10.1056/NEJMoa2201295. PMID: 35363951